कृपया अन्य खोज का प्रयास करें
CANbridge Pharmaceuticals Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide. The company offers Hunterase, an enzyme replacement therapy for the treatment of Hunter syndrome; NERLYNX (Neratinlib), a potent irreversible tyrosine kinase inhibitor for HER2-positive breast cancer; and Caphosol Mouth Rinse for temporary and persistent dryness of the mouth and throat. It also engages in the development of CAN008, a glycosylation fusion protein that blocks the interaction between the CD95 receptor and its cognate ligand CD95L through binding to CD95L; CAN108, an orally administered small molecule ASBT inhibitor; CAN106, a recombinant human monoclonal antibody that specifically binds to and neutralizes C5 in the complement system; CAN103, a recombinant human enzyme replacement therapy (ERT); CAN107, a fibroblast growth factor 23 (FGF23) blocking antibody; CAN104, a recombinant human ERT; CAN105, a bispecific antibody; CAN201, a gene therapy program that utilizes adeno-associated virus (AAV) sL65 capsid; and CAN202, a gene therapy program utilizing AAV sL65 capsid. CANbridge Pharmaceuticals Inc. was founded in 2012 and is headquartered in Suzhou, China.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Peng Kuan Chan | 59 | 2021 | Independent Non-Executive Director |
Richard James Gregory | 65 | 2020 | Independent Non-Executive Director |
James Qun Xue | 53 | 2018 | Founder, Chairman of the Board, CEO & Member of Strategic Advisory Board |
James Arthur Geraghty | 68 | 2018 | Independent Non-Executive Director |
Kan Chen | 40 | 2021 | Non-Executive Director |
Edward Hu | 60 | 2022 | Non-Executive Director |
Mark A. Goldberg | 69 | - | Member of Strategic Advisory Board |
Anthony Amato | - | 2022 | Member of Scientific Advisory Board |
Sushrut Waikar | - | 2022 | Member of Scientific Advisory Board |
Lan Hu | 54 | 2022 | Independent Non-Executive Director |
Guangping Gao | - | 2020 | Member of Strategic Advisory Board |
Robert Colvin | - | 2022 | Member of Scientific Advisory Board |
Richard Polisson | - | 2022 | Member of Scientific Advisory Board |
Jean Francis | - | 2022 | Member of Scientific Advisory Board |
Brian Weinshenker | - | 2022 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है